Evidence map›Paper›PMID 28437464›Full record

ArticlePloS one2017

Inhibition of αvβ3 integrin induces loss of cell directionality of oral squamous carcinoma cells (OSCC).

Cyntia F Montenegro, Bruna C Casali, Rafael L B Lino, Bianca C Pachane, Patty K Santos, Alan R Horwitz, Heloisa S Selistre-de-Araujo, Marcelo L Lamers

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Recombinant RGD-disintegrin DisBa-01 blocks integrin αCell communication and signaling : CCS · 2019
    Article
  12. Article
  13. Review
  14. Article
  15. Alternagin-C binding to αThe journal of venomous animals and toxins including tropical diseases · 2018
    Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Cyntia F MontenegroDepartment of Physiological Sciences, Center of Biological and Health Science, Federal University of São Carlos, Rod. Washington Luis, São Carlos, São Paulo, Brazil, CEP.
Bruna C CasaliDepartment of Physiological Sciences, Center of Biological and Health Science, Federal University of São Carlos, Rod. Washington Luis, São Carlos, São Paulo, Brazil, CEP.
Rafael L B LinoDepartment of Physiological Sciences, Center of Biological and Health Science, Federal University of São Carlos, Rod. Washington Luis, São Carlos, São Paulo, Brazil, CEP.
Bianca C PachaneDepartment of Physiological Sciences, Center of Biological and Health Science, Federal University of São Carlos, Rod. Washington Luis, São Carlos, São Paulo, Brazil, CEP.
Patty K SantosDepartment of Physiological Sciences, Center of Biological and Health Science, Federal University of São Carlos, Rod. Washington Luis, São Carlos, São Paulo, Brazil, CEP.
Alan R HorwitzDepartment of Cell Biology, University of Virginia, School of Medicine, Charlottesville, Virginia, United States of America.
Heloisa S Selistre-de-AraujoDepartment of Physiological Sciences, Center of Biological and Health Science, Federal University of São Carlos, Rod. Washington Luis, São Carlos, São Paulo, Brazil, CEP.ORCID http://orcid.org/0000-0002-2372-7814
Marcelo L LamersDepartment of Morphological Sciences, Institute of Basic Health Sciences, Federal University of Rio Grande do Sul, Rua Sarmento Leite, Porto Alegre, RS, Brazil, CEP.
Universidade Federal de São Carlos · BRUniversidade Federal do Rio Grande do Sul · BRUniversity of Virginia · US

Funding

DETERMINANTS OF MYOGENIC MEMBRANE PHENOMENAR01GM023244 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HORWITZ, ALAN F. "RICK" · 1985 to 2014
$6.7M
DETERMINANTS OF MYOGENIC MEMBRANE PHENOMENAR37GM023244 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HORWITZ, ALAN F · 1992 to 2002
$1.1M
NIGMS NIH HHS R01 GM023244NIGMS NIH HHS R37 GM023244
6 · The paper itself

Abstract

The connective tissue formed by extracellular matrix (ECM) rich in fibronectin and collagen consists a barrier that cancer cells have to overpass to reach blood vessels and then a metastatic site. Cell adhesion to fibronectin is mediated by αvβ3 and α5β1 integrins through an RGD motif present in this ECM protein, thus making these receptors key targets for cell migration studies. Here we investigated the effect of an RGD disintegrin, DisBa-01, on the migration of human fibroblasts (BJ) and oral squamous cancer cells (OSCC, SCC25) on a fibronectin-rich environment. Time-lapse images were acquired on fibronectin-coated glass-bottomed dishes. Migration speed and directionality analysis indicated that OSCC cells, but not fibroblasts, showed significant decrease in both parameters in the presence of DisBa-01 (1μM and 2μM). Integrin expression levels of the α5, αv and β3 subunits were similar in both cell lines, while β1 subunit is present in lower levels on the cancer cells. Next, we examined whether the effects of DisBa-01 were related to changes in adhesion properties by using paxillin immunostaining and total internal reflection fluorescence TIRF microscopy. OSCCs in the presence of DisBa-01 showed increased adhesion sizes and number of maturing adhesion. The same parameters were analyzed usingβ3-GFP overexpressing cells and showed that β3 overexpression restored cell migration velocity and the number of maturing adhesion that were altered by DisBa-01. Surface plasmon resonance analysis showed that DisBa-01 has 100x higher affinity for αvβ3 integrin than forα5β1 integrin. In conclusion, our results suggest that the αvβ3 integrin is the main receptor involved in cell directionality and its blockage may be an interesting alternative against metastasis.

Indexed as

Carcinoma, Squamous CellCell AdhesionCell Line, TumorCell MovementCrotalid VenomsDisintegrinsExtracellular MatrixFibroblastsFibronectinsHumansIntegrin alphaVbeta3Mouth NeoplasmsCrotalid VenomsDisBa-01, Bothrops alternatusDisintegrinsFibronectinsIntegrin alphaVbeta3

Identifiers

PMID28437464
PMCPMC5402964
OpenAlexW2607759647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.